GZBO
Ongoing
-
Adelaide SA
Effect of Retatrutide on participants with CVD and/or CKD.
- Closed to screening
- Monthly self-administered injections (similar to Epipen)
Requirements
- BMI > 27
- Established CKD and/or CVD
Outpatient Visit
- Clinic visits every 1–2 months
- 2-year extension for participants who completed the study on medication
- All participants receive Retatrutide during the extension period
Payment / Remuneration
- Reimbursed for travel